Posted in News on 16-10-2025

Castor Catalyst: Launching Self-Driving Clinical Trials with Google Cloud AI

Castor has launched Castor Catalyst, an innovative AI-powered platform developed in collaboration with Google Cloud. Built on Google’s Gemini models and Vertex AI, Catalyst is pioneering the concept of “self-driving clinical trials”. This solution automates the most burdensome and repetitive tasks in clinical research, addressing bottlenecks in the life sciences industry. By creating human-supervised, automated workflows, Castor aims to achieve a 50% reduction in manual effort in Phase 2/3 studies, drastically cutting costs, time, and errors, and accelerating the generation of regulatory-grade Real-World Evidence (RWE).


Learn more
Posted in News on 05-06-2025

Castor Bolsters Remote Study Engagement with Streamlined Participant Workflow

OTP login is now standard in Castor’s eConsent platform. No account setup or passwords to create. Participants receive a one-time code, enter it, and move straight into the study flow—landing page, screener, consent. The result: >98% screener completion in a recent real-world study. Castor doesn’t treat login as an afterthought. This is built-in, not bolted on. If your platform still relies on email links and account creation, you’re losing participants before the study even starts.


Learn more
Posted in News on 14-02-2025

Castor Steps Up to Preserve Critical Research Amid NIH Funding Cuts

Castor has announced free access to its clinical trial technology platform for U.S. researchers impacted by recent NIH funding cuts. Through the Castor for Impact Program, investigators can maintain data integrity, streamline workflows, and keep projects moving forward, despite reduced indirect cost allocations threatening vital scientific progress and ongoing discovery.


Learn more
Loading